Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemiaAndreas Burchert, Andreas Neubauer, Stefan Wölfl et al.|Blood|2002Cited by 136
Expression of Interferon Regulatory Factor 4 in Chronic Myeloid Leukemia: Correlation With Response to Interferon Alfa TherapyManuel Schmidt, Andreas Neubauer, Gerhard Ehninger et al.|Journal of Clinical Oncology|2000Cited by 51
Final results of patients with metastatic renal cell carcinoma treated with MGN1601 in the ASET study.Viktor Grünwald, Burghardt Wittig, Steffen Weikert et al.|Journal of Clinical Oncology|2014Cited by 7
Lefitolimod vs standard of care (SOC) for patients with metastatic colorectal cancer (mCRC) responding to first-line standard treatment: Results from the randomized phase III IMPALA trialDavid Cunningham, Dirk Arnold, Ramón Salazar et al.|Annals of Oncology|2019Cited by 6
ASET study: Long-term follow-up data of patients with metastatic renal cell carcinoma treated with MGN1601.Viktor Gruenwald, Burghardt Wittig, Steffen Weikert et al.|Journal of Clinical Oncology|2014Cited by 4